Objective To examine the most common long‐term and late effects of breast cancer
treatment, the American Society of Clinical Oncology guidelines for surveillance, and …

Background Cardiovascular disease is the primary cause of death among patients with
breast cancer. However, the association of cardiovascular-disease risk factors (CVD-RFs) …

Doxorubicin (DOX)-induced cardiotoxicity impairs the quality of life of cancer patients during
or after DOX treatment, and it is imperative to explore a novel strategy to address this …

Background Trastuzumab following anthracycline causes cardiotoxicity in up to 28% of
patients. Although the cardiotoxicity is often irreversible once cardiac dysfunction is …

Adjuvant chemotherapy improves survival of patients with stage I–III breast cancer but it is
being increasingly recognized that the benefit is not equal for all patients. Molecular …

Objectives: The objective of this study was to evaluate the changes in three-dimensional
(3D) speckle-tracking echocardiography–derived measures of mechanics and their …

Cancer and cardiovascular disorders are known as the two main leading causes of mortality
worldwide. Cardiotoxicity is a critical and common adverse effect of cancer-related …

Background Cancer survivors have a higher risk of developing and dying from
cardiovascular disease (CVD) compared to the general population. We sought to determine …

Cardiotoxicity due to cancer treatment is of rising concern, for both cardiologists and
oncologists, because it may have a significant impact on cancer patient management and …

Aims The aim of this study was to assess whether baseline echocardiographic measures of
left ventricular (LV) size and function predict the development of symptomatic heart failure or …